<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2021.638640</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Silver Nanoparticles Induce a <italic>Triclosan-Like</italic> Antibacterial Action Mechanism in Multi-Drug Resistant <italic>Klebsiella pneumoniae</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Pareek</surname> <given-names>Vikram</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1189905/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Devineau</surname> <given-names>St&#x00E9;phanie</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1163981/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sivasankaran</surname> <given-names>Sathesh K.</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/620817/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Bhargava</surname> <given-names>Arpit</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Panwar</surname> <given-names>Jitendra</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/1190015/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Srikumar</surname> <given-names>Shabarinath</given-names></name>
<xref ref-type="aff" rid="aff5"><sup>5</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/224927/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Fanning</surname> <given-names>S&#x00E9;amus</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff6"><sup>6</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x002A;</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x2020;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/85697/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>UCD-Centre for Food Safety, UCD School of Public Health, Physiotherapy and Sports Science, University College Dublin</institution>, <addr-line>Dublin</addr-line>, <country>Ireland</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Biological Sciences, Birla Institute of Technology and Science</institution>, <addr-line>Pilani</addr-line>, <country>India</country></aff>
<aff id="aff3"><sup>3</sup><institution>Universit&#x00E9; de Paris</institution>, <addr-line>BFA, UMR 8251, CNRS, Paris</addr-line>, <country>France</country></aff>
<aff id="aff4"><sup>4</sup><institution>Genome Informatics Facility, Iowa State University</institution>, <addr-line>Ames, IA</addr-line>, <country>United States</country></aff>
<aff id="aff5"><sup>5</sup><institution>Department of Food, Nutrition and Health, College of Food and Agriculture, UAE University</institution>, <addr-line>Al Ain</addr-line>, <country>United Arab Emirates</country></aff>
<aff id="aff6"><sup>6</sup><institution>Institute for Global Food Security, Queen&#x2019;s University Belfast</institution>, <addr-line>Belfast</addr-line>, <country>United Kingdom</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Jong H. Kim, Agricultural Research Service, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Anima Nanda, Sathyabama Institute of Science and Technology, India; Sanjay Kumar Singh Patel, Konkuk University, South Korea</p></fn>
<corresp id="c001">&#x002A;Correspondence: Jitendra Panwar, <email>jpanwar@pilani.bits-pilani.ac.in</email></corresp>
<corresp id="c002">S&#x00E9;amus Fanning, <email>sfanning@ucd.ie</email></corresp>
<fn fn-type="other" id="fn002"><p><sup>&#x2020;</sup>ORCID: Vikram Pareek, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0003-3980-1238">orcid.org/0000-0003-3980-1238</ext-link>; St&#x00E9;phanie Devineau, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0002-1133-5223">orcid.org/0000-0002-1133-5223</ext-link>; Sathesh K. Sivasankaran, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0003-3037-6001">orcid.org/0000-0003-3037-6001</ext-link>; Arpit Bhargava, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0001-6450-6551">orcid.org/0000-0001-6450-6551</ext-link>; Jitendra Panwar, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0002-0750-9745">orcid.org/0000-0002-0750-9745</ext-link>; Shabarinath Srikumar, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0003-3775-2831">orcid.org/0000-0003-3775-2831</ext-link>; S&#x00E9;amus Fanning, <ext-link ext-link-type="uri" xlink:href="http://orcid.org/0000-0002-1922-8836">orcid.org/0000-0002-1922-8836</ext-link></p></fn>
<fn fn-type="other" id="fn004"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>02</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>12</volume>
<elocation-id>638640</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>12</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>20</day>
<month>01</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2021 Pareek, Devineau, Sivasankaran, Bhargava, Panwar, Srikumar and Fanning.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Pareek, Devineau, Sivasankaran, Bhargava, Panwar, Srikumar and Fanning</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Infections associated with antimicrobial-resistant bacteria now represent a significant threat to human health using conventional therapy, necessitating the development of alternate and more effective antibacterial compounds. Silver nanoparticles (Ag NPs) have been proposed as potential antimicrobial agents to combat infections. A complete understanding of their antimicrobial activity is required before these molecules can be used in therapy. Lysozyme coated Ag NPs were synthesized and characterized by TEM-EDS, XRD, UV-vis, FTIR spectroscopy, zeta potential, and oxidative potential assay. Biochemical assays and deep level transcriptional analysis using RNA sequencing were used to decipher how Ag NPs exert their antibacterial action against multi-drug resistant <italic>Klebsiella pneumoniae</italic> MGH78578. RNAseq data revealed that Ag NPs induced a <italic>triclosan-like</italic> bactericidal mechanism responsible for the inhibition of the type II fatty acid biosynthesis. Additionally, released Ag<sup>+</sup> generated oxidative stress both extra- and intracellularly in <italic>K. pneumoniae</italic>. The data showed that <italic>triclosan-like</italic> activity and oxidative stress cumulatively underpinned the antibacterial activity of Ag NPs. This result was confirmed by the analysis of the bactericidal effect of Ag NPs against the isogenic <italic>K. pneumoniae</italic> MGH78578 &#x0394;<italic>soxS</italic> mutant, which exhibits a compromised oxidative stress response compared to the wild type. Silver nanoparticles induce a <italic>triclosan-like</italic> antibacterial action mechanism in multi-drug resistant <italic>K. pneumoniae</italic>. This study extends our understanding of anti-<italic>Klebsiella</italic> mechanisms associated with exposure to Ag NPs. This allowed us to model how bacteria might develop resistance against silver nanoparticles, should the latter be used in therapy.</p>
</abstract>
<kwd-group>
<kwd><italic>Klebsiella pneumoniae</italic></kwd>
<kwd>silver nanoparticles</kwd>
<kwd>RNA sequencing</kwd>
<kwd>soxS</kwd>
<kwd>triclosan</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="74"/>
<page-count count="12"/>
<word-count count="0"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title>Introduction</title>
<p>Antimicrobial resistance (AMR) is responsible for approximately 700,000 deaths annually across the globe and this number is expected to increase further if new measures are not adopted and antibacterial compounds discovered (<xref ref-type="bibr" rid="B70">World Health Organization, 2019</xref>). The emergence of multi-drug resistance (MDR) in various pathogenic bacterial species represents a serious public health challenge (<xref ref-type="bibr" rid="B43">Logan and Weinstein, 2017</xref>; <xref ref-type="bibr" rid="B13">Cassini et al., 2019</xref>), leading to hospital- and community-acquired infections, which are difficult to treat and control (<xref ref-type="bibr" rid="B56">Pendleton et al., 2013</xref>; <xref ref-type="bibr" rid="B36">Klemm et al., 2018</xref>). Since AMR is estimated to overtake cancer as the main cause of death in 50 years, innovative approaches including the development of novel antimicrobial strategies using silver nanoparticles (Ag NPs) are required (<xref ref-type="bibr" rid="B31">Huh and Kwon, 2011</xref>; <xref ref-type="bibr" rid="B25">Gupta et al., 2019</xref>; <xref ref-type="bibr" rid="B34">Kalia et al., 2019</xref>).</p>
<p><italic>Klebsiella pneumoniae</italic> is one of the members of the ESKAPE pathogens (representing <italic>Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa</italic>, and <italic>Enterobacter</italic> spp.) (<xref ref-type="bibr" rid="B56">Pendleton et al., 2013</xref>). It is a member of Enterobacteriaceae family&#x2014;Gram-negative, non-motile, and rod-shaped. This bacterium is considered an opportunistic pathogen commonly found in the intestine, mouth, and skin of humans. It is mainly associated with hospital-acquired infections (nosocomial infections) and responsible for respiratory/urinary tract infections, pneumonia, and sepsis (<xref ref-type="bibr" rid="B57">Podschun and Ullmann, 1998</xref>; <xref ref-type="bibr" rid="B39">Lee and Burgess, 2012</xref>; <xref ref-type="bibr" rid="B70">World Health Organization, 2019</xref>). This pathogen can also form biofilms on indwelling medical devices leading to persistent nosocomial infection (<xref ref-type="bibr" rid="B32">Jagnow and Clegg, 2003</xref>; <xref ref-type="bibr" rid="B40">Li et al., 2014</xref>). About 25% of nosocomial <italic>K. pneumoniae</italic> were found to be resistant to carbapenem-based compounds (<xref ref-type="bibr" rid="B28">Han et al., 2016</xref>; <xref ref-type="bibr" rid="B4">Anes et al., 2017</xref>). <italic>K. pneumoniae</italic> were also found to be resistant to colistin, a last-line antibiotic (<xref ref-type="bibr" rid="B6">Antoniadou et al., 2007</xref>; <xref ref-type="bibr" rid="B49">Neuner et al., 2011</xref>). The emergence of AMR in <italic>K. pneumoniae</italic> against critically important classes of antibiotics represents a major threat to conventional clinical therapy (<xref ref-type="bibr" rid="B40">Li et al., 2014</xref>; <xref ref-type="bibr" rid="B30">Hu et al., 2020</xref>). Novel antibacterial strategies are required to overcome this challenge (<xref ref-type="bibr" rid="B1">Adamo and Margarit, 2018</xref>; <xref ref-type="bibr" rid="B48">Mulani et al., 2019</xref>).</p>
<p>Silver and other metals such as copper and zinc have historically been used as potential antibacterial agents (<xref ref-type="bibr" rid="B2">Alexander, 2009</xref>; <xref ref-type="bibr" rid="B58">Rai et al., 2012</xref>). Antibacterial activity of silver can vary depending on its chemical form (<xref ref-type="bibr" rid="B47">Mijnendonckx et al., 2013</xref>; <xref ref-type="bibr" rid="B41">Li et al., 2016</xref>; <xref ref-type="bibr" rid="B72">Zheng et al., 2018</xref>). Metallic forms continuously release small numbers of ions, which makes it a slow-acting agent, whilst the ionic form is more efficient. Although Ag<sup>+</sup> is reported to exhibit better antibacterial activity (<xref ref-type="bibr" rid="B60">Randall et al., 2012</xref>), direct exposure to mammalian cells has toxic side effects that limit its application in therapy (<xref ref-type="bibr" rid="B16">Chernousova and Epple, 2013</xref>; <xref ref-type="bibr" rid="B68">Vimbela et al., 2017</xref>). In contrast, Ag NPs provide a greater surface area, leading to a more controlled release of Ag<sup>+</sup> (<xref ref-type="bibr" rid="B22">Dur&#x00E1;n et al., 2016</xref>). Hence, this form has potential as an antibacterial compound (<xref ref-type="bibr" rid="B62">Roe et al., 2008</xref>; <xref ref-type="bibr" rid="B35">Kang et al., 2019</xref>). Green synthesis of silver NPs was also developed by different groups (<xref ref-type="bibr" rid="B64">Sharma et al., 2009</xref>; <xref ref-type="bibr" rid="B18">Chowdhury et al., 2014</xref>; <xref ref-type="bibr" rid="B52">Otari et al., 2017</xref>). Despite these advantages, little is known about the antibacterial action mechanisms of Ag NP based formulations.</p>
<p>We synthesized lysozyme coated Ag NPs (L-Ag NPs) and characterized their antibacterial mechanism against MDR <italic>K. pneumonia</italic> MGH78578 using chemical analysis, biochemical assays and deep-level RNA sequencing. Our data revealed that L-Ag NPs induced a <italic>triclosan-like</italic> antibacterial effect against MDR <italic>K. pneumoniae.</italic> The inhibition of the type II fatty acid biosynthesis along with Ag<sup>+</sup> induced oxidative stress were responsible for the anti-<italic>K. pneumoniae</italic> effect. To the best of our knowledge, this is the first study that reports the triclosan-like antimicrobial effect of silver NPs and a full transcriptional analysis of their antibacterial action against <italic>K. pneumoniae</italic>. Our results provide molecular insights into how bacteria might deploy antibacterial strategies to counteract the toxic effects of Ag NPs. This allowed us to model how <italic>K. pneumoniae</italic> might develop resistance against Ag NPs (<xref ref-type="bibr" rid="B17">Chopra, 2007</xref>).</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2.SS1">
<title>Bacteria and Media</title>
<p><italic>Klebsiella pneumoniae</italic> MGH78578 (ATCC<sup>&#x00AE;</sup> 700721) is a clinical isolate chosen for its MDR phenotype (<xref ref-type="bibr" rid="B50">Ogawa et al., 2005</xref>; <xref ref-type="bibr" rid="B5">Anes et al., 2019</xref>) and the availability of its whole genome sequence (NC_009648.1). Bacteria were grown in Luria Bertani (LB) and modified LB (mLB) media constituted without NaCl (<xref ref-type="bibr" rid="B14">Chambers et al., 2013</xref>; <xref ref-type="bibr" rid="B11">Bhargava et al., 2018</xref>). Bacteria were recovered from long-term storage (at &#x2212;80&#x00B0;C in glycerol stocks) in mLB medium (casein enzyme hydrolysate 10 g L<sup>&#x2013;1</sup> and yeast extract 5 g L<sup>&#x2013;1</sup>, pH 7.2 &#x00B1; 0.2) for 12 h at 37&#x00B0;C with shaking (150 rpm). For the preparation of inoculum, an overnight grown bacterial culture was inoculated into freshly prepared mLB medium and grown until the mid-log phase (OD<sub>600</sub><sub>nm</sub> 0.5&#x2013;0.6). An overnight grown bacterial culture (approximately 10<sup>7</sup> CFU mL<sup>&#x2013;1</sup>) was inoculated separately in freshly prepared LB and mLB broth medium. Bacterial growth was determined by measuring the optical density (OD) at 600 nm at 2 h time intervals. Biological experiments were carried out in both technical and biological duplicates.</p>
</sec>
<sec id="S2.SS2">
<title>Synthesis of L-Ag NPs</title>
<p>L-Ag NPs were synthesized following a protocol adapted from <xref ref-type="bibr" rid="B8">Ashraf et al. (2014</xref>; see <xref ref-type="supplementary-material" rid="DS1">Supplementary Material</xref>). To determine the size, shape, crystallinity and surface capping, L-Ag NPs were characterized by Transmission Electron Microscopy (TEM), Energy Dispersive Spectroscopy (EDS) on a Quantax EDS (Bruker AXS, Coventry, United Kingdom), X-ray Diffraction (XRD) on a Rigaku MiniFlex Benchtop XRD System (Rigaku Company, United States), UV-vis spectroscopy on a V-630 UV-vis spectrophotometer (Jasco Corporation, Tokyo, Japan), and Fourier Transform Infrared spectroscopy (FTIR) on a Prestige-21 FTIR Spectrometer (Shimadzu, Nakagyo, Japan). The zeta potential of L-Ag NPs was measured with a Zetasizer Nano ZS (Malvern Instruments, United Kingdom). The acellular oxidative potential of L-Ag NPs was assessed by measuring the depletion in antioxidants (uric acid, ascorbic acid, reduced glutathione) by HPLC following incubation of L-Ag NPs in a simplified synthetic respiratory tract lining fluid for 4 h at 37&#x00B0;C (<xref ref-type="bibr" rid="B19">Crobeddu et al., 2017</xref>). The dissolution kinetics of L-Ag NPs in mLB was measured by inductively coupled plasma optical emission spectrometry (ICP-OES) (Avio 200, PerkinElmer, United States). All measurements were performed in duplicate. The detailed protocols are described in the <xref ref-type="supplementary-material" rid="DS1">Supplementary Information file</xref>. Freshly prepared L-Ag NPs were used for all the experiments.</p>
</sec>
<sec id="S2.SS3">
<title>Antibacterial Susceptibility Determinations</title>
<p>The minimum inhibitory concentration (MIC) was determined using the broth microdilution assay following CLSI guidelines. Bacterial cells were exposed to L-Ag NPs (ranging from 0.5&#x2013;64 &#x03BC;g (Ag) mL<sup>&#x2013;1</sup>) and incubated at 37&#x00B0;C in the dark for 24 h. Bacterial growth was determined by measuring the OD<sub>600 nm</sub>. In addition, the free lysozyme was tested in parallel for any antibacterial activity. Bacterial cells exposed to L-Ag NPs were spread plated and incubated for 12 h at 37&#x00B0;C to determine the minimum bactericidal concentration (MBC). Media without L-Ag NPs and bacterial cells were used as positive- and negative-controls, respectively (<xref ref-type="bibr" rid="B11">Bhargava et al., 2018</xref>). All experiments were done in biological duplicates and the results are represented as mean &#x00B1; standard deviation.</p>
</sec>
<sec id="S2.SS4">
<title>Mode of Action Studies-Measurement of Reactive Oxygen Species (ROS)</title>
<p>The generation of ROS inside the bacterial cell following exposure to L-Ag NPs was measured using a 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA) assay (<xref ref-type="bibr" rid="B69">Wang and Joseph, 1999</xref>). DCFH-DA was added to the bacterial cell suspension at a final concentration of 10 &#x03BC;M and incubated for 1 h at 37&#x00B0;C in the dark. Free dye was then separated from the DCFH-DA loaded bacterial cells by centrifugation at 8,000 rpm for 15 min followed by washing with PBS. Bacterial cells were exposed to different (sub)-MIC concentrations of L-Ag NPs (i.e., MIC<sub>25</sub>, MIC<sub>50</sub>, MIC<sub>75</sub>, and MIC<sub>100</sub>) for 30 min at 37&#x00B0;C in fresh mLB medium with shaking (150 rpm). The fluorescence intensity of dichlorodihydrofluorescein (DCF) was detected using a VICTOR X Multilabel Plate Reader (PerkinElmer, United States) at an excitation and emission wavelength of 485 and 535 nm, respectively. The experiments were performed in duplicates and the results expressed as mean &#x00B1; standard deviation.</p>
<p>The effect of L-Ag NPs on the bacterial cell envelope was examined by TEM. To prepare sample for TEM analysis, bacterial cells exposed to MIC<sub>75</sub> L-Ag NPs were centrifuged at 8,000 rpm for 10 min. Subsequently, the supernatant was discarded, and the bacterial pellet was washed twice with PBS followed by fixation in 2.5% v/v electron microscopy grade glutaraldehyde in 0.05 M sodium cacodylate buffer pH 7.2 for 2 h at 4&#x00B0;C. TEM samples were prepared by drop-casting the bacterial cell suspension on to a carbon-coated copper grid that was later imaged on a Hitachi H-7650 TEM instrument (Hitachi High-Technologies Corporation, Tokyo, Japan) at an acceleration voltage of 100 kV. Bacterial cells that were not exposed to L-Ag NPs were used as the control. A minimum number of 50 bacterial cells were analyzed on different TEM images in each condition.</p>
<p>The membrane damage was analyzed using the MDA and anthrone assays. Bacterial cells were treated with different (sub)-MIC concentrations of L-Ag NPs, i.e., MIC<sub>25</sub>, MIC<sub>50</sub>, MIC<sub>75</sub>, and MIC<sub>100</sub>. The determination of MDA concentration was done as described previously (<xref ref-type="bibr" rid="B12">Buege and Aust, 1978</xref>). The anthrone assay was done as described previously (<xref ref-type="bibr" rid="B11">Bhargava et al., 2018</xref>). The experiments were performed in biological duplicates and the results expressed as mean &#x00B1; standard deviation.</p>
<p>The intracellular concentration of Ag was measured by ICP-OES following exposure to MIC<sub>75</sub> L-Ag NPs for 5, 30, and 60 min at 37&#x00B0;C. A freshly grown bacterial culture (approximately 10<sup>7</sup> CFU mL<sup>&#x2013;1</sup>) was exposed to MIC<sub>75</sub> L-Ag NPs followed by incubation for 5, 30, and 60 min at 37&#x00B0;C in mLB. After incubation, bacterial cells were pelleted by centrifugation at 8,000 rpm for 10 min at 4&#x00B0;C then dried and digested in a 1 mL mixture of H<sub>2</sub>O<sub>2</sub>:HNO<sub>3</sub> (50:50) for 2 h. After acid digestion, the final volume was made up to 10 mL and filtered using 0.22 &#x03BC;m syringe filter. The silver concentration of the sample was measured by ICP-OES (Avio 200, PerkinElmer, United States) (<xref ref-type="bibr" rid="B46">McQuillan et al., 2012</xref>). Untreated bacterial cells were taken as a control for the respective time points. The experiments were performed in biological duplicates and the results expressed as mean &#x00B1; standard deviation. Detailed protocols are described in SI.</p>
</sec>
<sec id="S2.SS5">
<title>RNA Sequencing</title>
<p>A freshly grown culture of <italic>K. pneumoniae</italic> MGH78578 from mid-log<sub>10</sub> phase (approximately 10<sup>7</sup> CFU mL<sup>&#x2013;1</sup>) was exposed to MIC<sub>75</sub> L-Ag NPs for 5 and 30 min at 37&#x00B0;C in mLB broth. Bacterial cells not exposed to L-Ag NPs were selected as a control for each time point. RNA was isolated using RNAeasy extraction kit (Qiagen) and treated with Turbo DNase kit (Ambion&#x2019;s). RNA integrity was assessed using a Bioanalyzer 2100 RNA 6000 nanochip (Agilent Technologies). RNA library sequencing was performed at the Centre for Genomic Research, University of Liverpool, United Kingdom. Ribosomal RNA was removed with a Ribo-Zero rRNA removal kit (Illumina). Libraries were prepared with NEBNext Directional RNA Library Prep Kit (BioLabs). Pooled libraries (<xref ref-type="supplementary-material" rid="FS1">Supplementary Table 1</xref>) were loaded on cBot (Illumina) and cluster generations was performed. Single-sequencing using 150 bp read length was performed on lane of the HiSeq 4000 sequencer (Illumina). Raw sequencing data was processed as described in <xref ref-type="supplementary-material" rid="DS1">Supplementary Material</xref>. The RNAseq data produced from the present work were deposited to the NCBI-GEO database and are available under the accession number <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="GSE151953">GSE151953</ext-link>.</p>
</sec>
<sec id="S2.SS6">
<title>Comparative Gene Expression Analysis With <italic>E. coli</italic> MGH1655 Exposed to Individual Antibiotics</title>
<p>A comparison of our transcriptional data with the global transcriptome profiling of <italic>E. coli</italic> MGH1665 K12 strain exposed to 37 antibiotics was carried out. Only those genes that gave statistically significant differential expression patterns were selected from both datasets. Our gene expression dataset was compared to each of the 37 <italic>E. coli</italic> transcriptional profiles and genes that had similar expression patterns (both up-and down-regulation) were counted.</p>
</sec>
<sec id="S2.SS7">
<title>Validation of RNA-Seq Data by Quantitative RT-PCR Analysis</title>
<p>RNA isolated from the samples were converted to cDNA by using high-capacity RNA to cDNA kit (Thermo Fisher Scientific, Ireland). Primers based on the selected genes of interest were designed with 6-FAM/ZEN/IBFQ double-quenched probes and synthesized commercially by Integrated DNA Technologies (IDT, Belgium) (<xref ref-type="supplementary-material" rid="FS1">Supplementary Table 2</xref>). The cDNA was used as a template and analysis was done by the addition of PrimeTime Gene Expression Master Mix. qRT-PCR was performed in an Eppendorf Mastercycler realplex ep gradient S (Eppendorf, United Kingdom). This analysis was carried out in two biological replicates each along with three technical replicates. The fold-change in the expression of the genes of interest was determined by the method of <xref ref-type="bibr" rid="B42">Livak and Schmittgen (2001)</xref>, i.e., 2<sup>&#x2013;&#x0394;&#x0394;Ct</sup> method using <italic>rho</italic> as a housekeeping gene.</p>
</sec>
<sec id="S2.SS8">
<title>Statistical Analysis</title>
<p>The results for the biochemical assay were analyzed using unpaired Student <italic>t</italic>-test as appropriate for the dataset. The qRT-PCR measurements data were statistically analyzed using Prism software (v. 8.0 GraphPad Software) following the two-way analysis of variance. Boneferroni method was used to analyze the multiple comparisons. The symbol &#x201C;ns&#x201D; used in the graphs corresponds to statistically non-significant with <italic>p</italic> &#x003E; 0.05. The asterisk symbols in the graphs correspond to <sup>&#x2217;</sup><italic>p</italic> &#x2264; 0.05, <sup>&#x2217;&#x2217;</sup><italic>p</italic> &#x2264; 0.01, and <sup>&#x2217;&#x2217;&#x2217;</sup><italic>p</italic> &#x2264; 0.001. All the data points represent the mean of two independent measurements. The uncertainties were represented as standard deviations. In RNAseq results, NSE represents non-significant expression.</p>
</sec>
</sec>
<sec id="S3">
<title>Results and Discussion</title>
<sec id="S3.SS1">
<title>Synthesis and Characterization of L-Ag NPs</title>
<p>L-Ag NPs were synthesized by a co-reduction method wherein lysozyme functions both as a reducing and stabilizing agent using heat reflux action at 120&#x00B0;C (<xref ref-type="bibr" rid="B23">Eby et al., 2009</xref>; <xref ref-type="bibr" rid="B8">Ashraf et al., 2014</xref>). Lysozyme acts as a capping material devoid of enzymatic activity. We selected L-Ag NPs based on their bactericidal activity against MDR <italic>K. pneumoniae</italic> MGH78578. The synthesis of L-Ag NPs was associated with the appearance of the plasmon peak at 414 nm (<xref ref-type="fig" rid="F1">Figure 1A</xref>) (<xref ref-type="bibr" rid="B66">Singh et al., 2018</xref>). The average diameter of L-Ag NPs measured by TEM was 5.2 &#x00B1; 1.2 nm (<xref ref-type="fig" rid="F1">Figures 1B,C</xref>). The X-ray diffraction pattern obtained corresponds to the face-centered cubic lattice structure of crystalline silver (JCPDS file 04-0783) (<xref ref-type="fig" rid="F1">Figure 1D</xref> and <xref ref-type="supplementary-material" rid="FS1">Supplementary Figure 1</xref>) (<xref ref-type="bibr" rid="B33">Jain et al., 2011</xref>; <xref ref-type="bibr" rid="B53">Pareek et al., 2020</xref>). The surface charge of L-Ag NPs was estimated by measuring their zeta potential in water and modified LB (mLB) medium (devoid of NaCl) at 37&#x00B0;C. L-Ag NPs were found to be negatively charged in both conditions with &#x03B6; = &#x2212;38.2 &#x00B1; 1.6 mV in water and &#x03B6; = &#x2212;24.2 &#x00B1; 0.9 mV in mLB medium. The 1,632 cm<sup>&#x2013;1</sup> peak in the FTIR spectrum corresponds to the amide I vibration characteristic of the protein backbone, confirming the presence of lysozyme associated with Ag NPs (<xref ref-type="fig" rid="F1">Figure 1E</xref>) (<xref ref-type="bibr" rid="B9">Baker et al., 2014</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Characterization of L-Ag NPs. <bold>(A)</bold> UV-visible spectrum (inset shows a picture of the L-Ag NP suspension after synthesis). <bold>(B)</bold> TEM image. <bold>(C)</bold> Distribution of L-Ag NP diameter determined from TEM analysis. <bold>(D)</bold> XRD diffraction spectrum. <bold>(E)</bold> FTIR spectrum.</p></caption>
<graphic xlink:href="fmicb-12-638640-g001.tif"/>
</fig>
</sec>
<sec id="S3.SS2">
<title>L-Ag NPs Inhibit the Proliferation of <italic>K. pneumoniae</italic> MGH78578</title>
<p>In media with high salt content like chloride and phosphate, Ag NPs may aggregate and free Ag<sup>+</sup> can precipitate, potentially reducing their bactericidal activity (<xref ref-type="bibr" rid="B44">Lok et al., 2007</xref>; <xref ref-type="bibr" rid="B46">McQuillan et al., 2012</xref>; <xref ref-type="bibr" rid="B14">Chambers et al., 2013</xref>; <xref ref-type="bibr" rid="B54">Pareek et al., 2018</xref>). Hence, the bactericidal effect of L-Ag NPs against <italic>K. pneumoniae</italic> MGH78578 was assessed in mLB medium (LB medium devoid of NaCl) (<xref ref-type="bibr" rid="B55">Pelletier et al., 2010</xref>; <xref ref-type="bibr" rid="B15">Chatterjee et al., 2011</xref>). No significant difference between the growth of <italic>K. pneumoniae</italic> in mLB and LB media was observed (<xref ref-type="fig" rid="F2">Figure 2A</xref>) confirming mLB had no phenotypic effect. Approximately 3 &#x00D7; 10<sup>7</sup> CFU mL<sup>&#x2013;1</sup> log<sub>10</sub> phase bacterial cells were exposed to L-Ag NPs. The MIC of L-Ag NPs was 21 &#x03BC;g (Ag) mL<sup>&#x2013;1</sup> (<xref ref-type="fig" rid="F2">Figure 2B</xref>). To determine the bactericidal efficiency of L-Ag NPs, <italic>K. pneumoniae</italic> MGH78578 exposed to L-Ag NPs were spread plated and incubated for 12 h at 37&#x00B0;C. The MBC of L-Ag NPs was 45 &#x03BC;g (Ag) mL<sup>&#x2013;1</sup> (<xref ref-type="supplementary-material" rid="FS1">Supplementary Figure 2</xref>). These results show that L-Ag NPs inhibit the proliferation of <italic>K. pneumoniae</italic> MGH78578 at low concentrations.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption><p><bold>(A)</bold> Bacterial growth curve analysis of <italic>K. pneumoniae</italic> MGH78578 in LB and mLB media. <bold>(B)</bold> Determination of <italic>K. pneumoniae</italic> L-Ag NP MIC in mLB medium. <bold>(C)</bold> Dissolution kinetics of L-Ag NPs in mLB medium at 37&#x00B0;C.</p></caption>
<graphic xlink:href="fmicb-12-638640-g002.tif"/>
</fig>
</sec>
<sec id="S3.SS3">
<title>L-Ag NPs Generate ROS and Limited Membrane Damage in <italic>K. pneumoniae</italic> MGH78578</title>
<p>Reactive oxygen species (ROS) could be generated outside the bacterial cells by L-Ag NPs and released Ag<sup>+</sup> (<xref ref-type="bibr" rid="B38">Le Ouay and Stellacci, 2015</xref>). Limited dissolution of L-Ag NPs was observed in mLB media for 8 h at 37&#x00B0;C (<xref ref-type="fig" rid="F2">Figure 2C</xref>). Extracellular ROS production was evaluated by measuring the oxidative potential of L-Ag NPs in a simplified synthetic respiratory tract lining fluid. The depletion of antioxidants (uric acid, acetic acid, and reduced glutathione GSH) was also noted when measured by HPLC after 4 h incubation at 37&#x00B0;C (<xref ref-type="fig" rid="F3">Figure 3A</xref>) (<xref ref-type="bibr" rid="B19">Crobeddu et al., 2017</xref>). We observed a dose-dependent depletion in ascorbic acid and GSH (up to 100%), showing that, at low NP concentration, L-Ag NPs can generate ROS extracellularly.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption><p><bold>(A)</bold> Acellular oxidative potential of L-Ag NPs measured by the depletion of antioxidants, uric acid (UA), ascorbic acid (AA), and reduced glutathione (GSH), in simplified synthetic lung lining fluid at 37&#x00B0;C. <bold>(B)</bold> Analysis of the intracellular ROS generation in <italic>K. pneumoniae</italic> MGH78578 following exposure to L-Ag NPs by the DCFH-DA assay. <bold>(C,D)</bold> Representative TEM images of untreated <italic>K. pneumoniae</italic> (control) <bold>(C)</bold> and <italic>K. pneumoniae</italic> exposed to MIC<sub>75</sub> of L-Ag NPs <bold>(D)</bold>. <bold>(E,F)</bold> Membrane damage analysis of <italic>K. pneumoniae</italic> following exposure to L-Ag NPs. Analysis by MDA assay <bold>(E)</bold> and anthrone assay <bold>(F)</bold>. (&#x002A;<italic>p</italic> &#x2264; 0.05).</p></caption>
<graphic xlink:href="fmicb-12-638640-g003.tif"/>
</fig>
<p>Then, we measured the concentration of silver that enter <italic>K. pneumoniae</italic> MGH78578 by ICP-OES following treatment with L-Ag NPs for 5, 30, and 60 min. The uptake of silver, either in the form of L-Ag NPs or Ag<sup>+</sup>, was proportional to the time duration of treatment (<xref ref-type="supplementary-material" rid="FS1">Supplementary Figure 3</xref>). To determine whether ROS were also produced inside the bacterial cells following exposure to L-Ag NPs, we used the DCFH-DA assay (<xref ref-type="bibr" rid="B7">Aranda et al., 2013</xref>). A dose-dependent increase in the intracellular ROS was observed, a reflection of the oxidative stress external to the bacterial cell (<xref ref-type="fig" rid="F3">Figure 3B</xref>).</p>
<p>The severe oxidative stress induced by L-Ag NPs could lead to many downstream phenotypes in bacteria including compromised membrane integrity (<xref ref-type="bibr" rid="B22">Dur&#x00E1;n et al., 2016</xref>; <xref ref-type="bibr" rid="B72">Zheng et al., 2018</xref>; <xref ref-type="bibr" rid="B74">Zou et al., 2018</xref>; <xref ref-type="bibr" rid="B35">Kang et al., 2019</xref>). TEM analysis of <italic>K. pneumoniae</italic> did not show any change in the membrane integrity of the exposed bacterial cells (<xref ref-type="fig" rid="F3">Figures 3C,D</xref>). To verify this observation, we explored the degree of bacterial membrane damage in the whole population using an MDA assay. A limited though significant concentration-dependent increase in the level of lipid peroxidation was observed (<xref ref-type="fig" rid="F3">Figure 3E</xref>). Additionally, a concentration-dependent increase of carbohydrate release was observed following L-Ag NP exposure (<xref ref-type="fig" rid="F3">Figure 3F</xref>). Overall, our results show that L-Ag NPs induced limited bacterial membrane damage, a phenotype that was not observed by TEM.</p>
</sec>
<sec id="S3.SS4">
<title>Transcriptomic Profiling of L-Ag NPs Exposed <italic>K. pneumoniae</italic> MGH78578 Using RNA-Seq</title>
<p>We used RNA-seq to understand how <italic>K. pneumoniae</italic> MGH78578 responded to L-Ag NP exposure following a previously standardized protocol investigating the transcriptome of <italic>K. pneumoniae</italic> MGH78578 exposed to sub-inhibitory concentrations of a chemosensitizer (<xref ref-type="bibr" rid="B5">Anes et al., 2019</xref>). Here, we exposed <italic>K. pneumoniae</italic> MGH78578 to a sub-inhibitory concentration of L-Ag NPs at MIC<sub>75</sub> (15.8 &#x03BC;g (Ag) mL<sup>&#x2013;1</sup>) for a period of 5- and 30-min. The 5 min time point was used to identify the transcriptional signals associated with early exposure, whilst the 30 min time point demonstrated the adaptive responses of L-Ag NP exposed <italic>K. pneumoniae</italic> (replication time is 20 min). Approximately 336 million reads were obtained across all 8 libraries with an average of 42 million reads <italic>per</italic> library (<xref ref-type="supplementary-material" rid="FS1">Supplementary Table 1</xref>) sufficient for downstream transcriptomic analysis (<xref ref-type="bibr" rid="B27">Haas et al., 2012</xref>; <xref ref-type="bibr" rid="B5">Anes et al., 2019</xref>). The <italic>VOOM</italic> function in the <italic>limma</italic> package (<xref ref-type="bibr" rid="B61">Ritchie et al., 2015</xref>) was used to identify differentially regulated genes. We obtained statistically significant data <italic>p</italic> &#x2264; 0.05 for a total of 3,760 and 3,945 genes following 5 and 30 min exposure, respectively (<xref ref-type="fig" rid="F4">Figure 4A</xref> and <xref ref-type="supplementary-material" rid="DS1">Supplementary Dataset WS1</xref>). Statistically significant genes with a log<sub>2</sub> fold change expression of &#x2265;1.0 and &#x2264;&#x2212;1.0 (exposed <italic>vs.</italic> unexposed cells) were considered to be up- and down-regulated, respectively (<xref ref-type="bibr" rid="B20">Dash et al., 2018</xref>; <xref ref-type="bibr" rid="B5">Anes et al., 2019</xref>). For the post-5 min exposure, 1,008 genes were found to be upregulated and 1,063 genes were downregulated. At 30 min post exposure, 1,205 genes were found to be upregulated and 1,246 genes were downregulated (<xref ref-type="fig" rid="F4">Figure 4B</xref>). Among all the upregulated genes at the 5- and 30-min, 705 genes were found to be commonly upregulated, whereas 303 and 500 genes were uniquely upregulated at 5 and 30 min, respectively. For downregulated genes, 810 genes were found to be commonly downregulated at both time points, whereas 253 and 436 genes were specifically downregulated at 5 and 30 min (<xref ref-type="fig" rid="F4">Figure 4C</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption><p>Overview of the RNAseq analysis of <italic>K. pneumoniae</italic> MGH78578 following treatment with MIC<sub>75</sub> L-Ag NPs. <bold>(A)</bold> Statistically significant and non-significant genes recorded at 5 and 30 min post-treatment. <bold>(B)</bold> Statistically significant upregulated, downregulated and neutral genes identified at 5 and 30 min post-treatment. <bold>(C)</bold> Comparison of the upregulated, downregulated, and neutral genes identified at 5 and 30 min post-treatment.</p></caption>
<graphic xlink:href="fmicb-12-638640-g004.tif"/>
</fig>
<p>We selected representative genes related to the bacterial defense system (<italic>soxS</italic>), transcriptional regulator (<italic>ramA</italic>), outer membrane porin proteins (<italic>ompC</italic>), and virulence (<italic>rfaH</italic>) to validate our transcriptomic data using qRT-PCR. Gene expression analysis reflected a similar pattern of results when compared to RNA-seq data (<xref ref-type="supplementary-material" rid="FS1">Supplementary Figure 4</xref>).</p>
</sec>
<sec id="S3.SS5">
<title>Bacterial Oxidative Stress Response Following Exposure to L-Ag NP</title>
<p>Our RNA-seq data shows that the oxidative stress response induced by ROS generation is choreographed by both <italic>soxS</italic> and <italic>oxyR</italic>, two major transcriptional factors that respond to oxidative stress in Enterobacteriaceae (<xref ref-type="bibr" rid="B63">Seo et al., 2015</xref>). The OxyR system functions as a global regulator of peroxide stress whilst the SoxRS system is involved in the control of superoxide stress (<xref ref-type="bibr" rid="B73">Zheng et al., 1998</xref>; <xref ref-type="bibr" rid="B63">Seo et al., 2015</xref>). Increased intracellular ROS levels induce the oxidation of OxyR protein, which in turn activates detoxifying processes including heme biosynthesis, thiol-disulfide isomerization, among others (<xref ref-type="bibr" rid="B21">Dubbs and Mongkolsuk, 2012</xref>). In the case of the SoxRS regulon, oxidative stress causes the oxidization of the SoxR protein, which activates the <italic>soxS</italic> transcriptional regulator, thereby triggering a bacterial defense mechanism involving various efflux pumps and redox counter measures (<xref ref-type="bibr" rid="B63">Seo et al., 2015</xref>). In L-Ag NP exposed <italic>K. pneumoniae</italic> MGH78578, <italic>soxS</italic> was highly upregulated (300- and 88-fold in 5 and 30 min) and in contrast <italic>oxyR</italic> was moderately upregulated (approximately 5-fold in both time points). This suggested that the oxidative stress regulon was active throughout the 30 min of L-Ag NP exposure time, particularly for the <italic>soxS</italic> regulon.</p>
<p>To confirm this, we compared our RNA-seq dataset to the <italic>K. pneumoniae</italic> MGH78578 <bold>oxidative <italic>soxS</italic> regulon</bold> generated earlier (<xref ref-type="bibr" rid="B3">Anes et al., 2020</xref>). We found that of the 254 genes belonging to the <bold>oxidative <italic>soxS</italic> regulon</bold>, 129 (51%) had similar expression patterns in both datasets, confirming that the <italic>soxS</italic> regulon is activated in L-Ag NP exposed <italic>K. pneumoniae</italic> (<xref ref-type="supplementary-material" rid="DS1">Supplementary Dataset WS2</xref>). A typical example of <italic>soxS</italic> induction can be visualized in the expression of <italic>fpr</italic> (ferredoxin-NADP<sup>+</sup> reductase), which was induced at 22- and 9-fold at 5 and 30 min. In response to <italic>soxS</italic> activation, a redox neutralization process is triggered related to the overexpression of <italic>fpr</italic> by 4.5-fold at 5 min, that then reduced to 3.2-fold at 30 min post-treatment (<xref ref-type="bibr" rid="B37">Krapp et al., 2002</xref>).</p>
</sec>
<sec id="S3.SS6">
<title>Activation of Efflux Pumps Following Exposure to L-Ag NP</title>
<p>Bacteria activate various efflux pumps to expel the toxic Ag<sup>+</sup> (<xref ref-type="bibr" rid="B59">Randall et al., 2014</xref>; <xref ref-type="bibr" rid="B26">Gurbanov et al., 2018</xref>). Classic efflux pump-encoding genes such as <italic>acrAB-tolC</italic> (<xref ref-type="bibr" rid="B29">Hirakata et al., 2009</xref>; <xref ref-type="bibr" rid="B10">Baugh et al., 2013</xref>) and <italic>marRAB</italic> were found to be highly upregulated following treatment with L-Ag NPs, a feature that was sustained throughout the testing period of 30 min, possibly driven by the positive regulation <italic>via</italic> SoxS (<xref ref-type="bibr" rid="B63">Seo et al., 2015</xref>; <xref ref-type="bibr" rid="B3">Anes et al., 2020</xref>). Another efflux pump encoded by the <italic>silCFBA</italic> operon conferring a silver resistance phenotype was also upregulated (<xref ref-type="bibr" rid="B59">Randall et al., 2014</xref>; <xref ref-type="bibr" rid="B24">Elkrewi et al., 2017</xref>). Transcription of the <italic>silCFBA</italic> operon and <italic>silP</italic> are controlled by the <italic>silRS</italic>, which encodes a two-component system wherein SilR acts as a response regulator and SilS acts as a histidine kinase (<xref ref-type="bibr" rid="B67">Starodub and Trevors, 1989</xref>; <xref ref-type="bibr" rid="B45">Massani et al., 2018</xref>). SilP is a P-type ATPase efflux pump, which facilitates the passage of Ag<sup>+</sup> from cytoplasm to the periplasm. SilF acts as a chaperone and transfers Ag<sup>+</sup> from periplasm to the SilCBA complex, a three-protein dependent cation/proton antiporter system. Another protein from silver resistance system is SilE, present downstream to the <italic>silRS</italic> (<xref ref-type="fig" rid="F5">Figure 5</xref>) (<xref ref-type="bibr" rid="B67">Starodub and Trevors, 1989</xref>; <xref ref-type="bibr" rid="B45">Massani et al., 2018</xref>). Upregulation of <italic>silC/B/E/R/S/P</italic> and KPN_pKPN3p05946 genes were noted in our RNA-seq data showing the activation of efflux pumps, encoding a possible silver resistance in response to L-Ag NP exposure.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption><p>A model depicting the bactericidal action of L-Ag NPs on <italic>K. pneumoniae</italic> MGH78578. L-Ag NPs and silver ions (Ag<sup>+</sup>) enter the bacterial cell <italic>via</italic> outer membrane porins. Increasing cytoplasmic Ag<sup>+</sup> concentration elicits the production of reactive oxygen species (ROS) including superoxide radicals, which then activate the <italic>soxS</italic>-mediated oxidative stress response. The SilE efflux system functions to eliminate Ag<sup>+</sup> from the cytoplasm. RNA-seq data identified seven genes (denoted by the green arrowheads) associated with type II fatty acid biosynthesis that are down-regulated leading to reduced phospholipid biosynthesis. This reduction in phospholipid turnover will affect the membrane stability leading to cell lysis underpinning the bactericidal activity. Gray arrows represent genes that are activated. White arrows represent genes that are either not identified in the <italic>K. pneumoniae</italic> MGH78578 genome or not differentially regulated when the bacteria are exposed to L-Ag NPs.</p></caption>
<graphic xlink:href="fmicb-12-638640-g005.tif"/>
</fig>
</sec>
<sec id="S3.SS7">
<title>The Type II Fatty Acid Biosynthesis Genes Were Down-Regulated in L-Ag NP Exposed <italic>K. pneumoniae</italic> MGH78578</title>
<p>Since <italic>K. pneumoniae</italic> MGH78578 expressed an MDR phenotype (<xref ref-type="bibr" rid="B4">Anes et al., 2017</xref>), L-Ag NP exposure dependent activation of <italic>acrAB-tolC, marRAB</italic>, and <italic>sil</italic> genes should, in principle, confer silver resistance in <italic>K. pneumoniae</italic>. Additionally, the strong oxidative stress response should enable the bacterium to counter the oxidative stress induced by L-Ag NPs. Both of these mechanisms should render <italic>K. pneumoniae</italic> MGH78578 resistant against silver. However, <italic>K. pneumoniae</italic> MGH78578 was found to be susceptible to L-Ag NPs. We hypothesized that the bactericidal activity of L-Ag NPs could be due to a hitherto unknown mechanism, rather than the most commonly reported oxidative stress based bactericidal activity (<xref ref-type="bibr" rid="B22">Dur&#x00E1;n et al., 2016</xref>). To investigate, we compared our RNA-seq data to the transcriptional response of <italic>E. coli</italic> exposed to 37 antimicrobial compounds (<xref ref-type="bibr" rid="B51">O&#x2019;Rourke et al., 2020</xref>). This global transcriptional profile of <italic>E. coli</italic> exposed to 37 antibiotics generated a list of 447 genes whose signature expression pattern characterized the mechanism of action associated with each antibiotic, leading the authors to hypothesize that the antibacterial action mechanism of any unknown/uncharacterized compounds can be deduced by comparing the transcriptional profile of a compound of interest with that of these 447 <italic>E. coli</italic> MG1665 K12 genes. We compared our exposed <italic>K. pneumoniae</italic> MGH78578 transcriptional data set with each individual dataset obtained from <italic>E. coli</italic> global transcriptional profile. Our comparative analysis showed that the highest number of similarly expressed gene pairs were obtained from the <bold>triclosan exposure</bold> dataset, suggesting that exposure to L-Ag NPs induced a <italic>triclosan-like</italic> exposure response in <italic>K. pneumoniae</italic> MGH78578. Some 76% of the gene pairs (73/96) at 5 min L-Ag NP exposure (<xref ref-type="supplementary-material" rid="DS1">Supplementary Datasets WS3</xref>, <xref ref-type="supplementary-material" rid="DS1">WS4</xref>) and 74% (87/117) at 30 min exposure (<xref ref-type="supplementary-material" rid="DS1">Supplementary Datasets WS5</xref>, <xref ref-type="supplementary-material" rid="DS1">WS6</xref>) had similar expression patterns compared with the <italic>E. coli</italic> triclosan dataset.</p>
<p>Triclosan is a broad-spectrum antimicrobial compound that acts by inhibiting FabI (a NADH-dependent enoylacyl carrier), a protein belonging to the type II fatty acid biosynthesis, part of a well-conserved pathway that is essential for bacterial survival. Inhibition of fatty acid biosynthesis compromises the bacterial cell membrane. During exposure to L-Ag NPs, some <italic>K. pneumoniae</italic> MGH78578 genes associated with type II fatty acid biosynthesis including <italic>fabA/H/D/G/F/B</italic> were significantly downregulated particularly during the adaptive response at 30 min. The downregulation of the different <italic>fab</italic> genes signals a compromised type II fatty acid biosynthesis underpinning the <italic>triclosan-like</italic> L-Ag NP bactericidal activity. Importantly, <italic>fadL</italic> and <italic>fadD</italic> were downregulated. FadL is a porin that transports extracellular fatty acids across the outer membrane to the inner membrane where they are activated by acyl CoA synthetase FadD. Downregulation of both <italic>fadL</italic> and <italic>fadD</italic> shows that extracellular fatty acids are not transported leading to subsequent suppression of type II fatty acid biosynthesis pathway. We, however, did not observe any differential expression in the <italic>fabI</italic> gene, possibly because the triclosan affects FabI post-translationally.</p>
<p>Recently, the TraDIS-Xpress approach involving a transposon mutant library and massively parallel sequencing of transposon chromosome junctions was used to identify <italic>E. coli</italic> genes that respond to triclosan exposure (<xref ref-type="bibr" rid="B71">Yasir et al., 2020</xref>). In comparison with these data, we identified genes that were both enriched in the <italic>E. coli</italic> TraDIS-Xpress dataset and that were found to be differentially expressed in our <italic>K. pneumoniae</italic> MGH78578 dataset. Common genes like <italic>purL, purH, waeL, wzx</italic> were downregulated at either one or both time points while <italic>metB</italic> was upregulated. Similarly, <italic>K. pneumoniae</italic> MGH78578 genes like <italic>trkA, pcnB, infB</italic>, and <italic>ubiB/F</italic> were downregulated at least in one or both time points, while <italic>lonH</italic> was upregulated (<xref ref-type="supplementary-material" rid="DS1">Supplementary Dataset WS1</xref>). TraDIS-Xpress selected <italic>rbs</italic> in their triclosan exposure screen. In <italic>E. coli</italic>, RbsABC forms the ABC-type high-affinity D-ribose transporter, while RbsD/K phosphorylates D-ribose to D-ribose 5-phosphate (<xref ref-type="bibr" rid="B65">Shimada et al., 2013</xref>). Though we did not observe a statistically significant differential expression for <italic>rbsB</italic>, down-regulation was observed for <italic>rbsD</italic> and <italic>rbsC</italic>, showing similarly compromised D-ribose uptake. These common observations across different datasets gave confidence to our earlier observation that L-Ag NP exposure elicits a <italic>triclosan-like</italic> bactericidal effect in <italic>K. pneumoniae</italic> inhibiting type II fatty acid biosynthesis.</p>
</sec>
<sec id="S3.SS8">
<title>The L-Ag NP Based Antibacterial Action Is Cumulative of Oxidative Stress and Fatty Acid Biosynthesis Inhibition</title>
<p>We investigated whether the L-Ag NP based antibacterial effect was primarily due to type II fatty acid biosynthesis inhibition or as a cumulative effect of both oxidative stress and fatty acid biosynthesis inhibition. We exposed the isogenic <italic>K. pneumoniae MGH78578</italic>&#x0394;<italic>soxS</italic> mutant, which has a compromised oxidative stress response mechanism (<xref ref-type="bibr" rid="B3">Anes et al., 2020</xref>) to L-Ag NPs. The MIC of L-Ag NPs reduced to 15 &#x03BC;g mL<sup>&#x2013;1</sup> from 21 &#x03BC;g mL<sup>&#x2013;1</sup> showing that oxidative stress did contribute to a significant antibacterial effect. The antibacterial effect of L-Ag NPs is, therefore, a cumulative effect of both type II fatty acid biosynthesis inhibition and oxidative stress responses.</p>
</sec>
<sec id="S3.SS9">
<title>Concluding Observations</title>
<p>L-Ag NPs were very efficient in killing MDR <italic>K. pneumoniae</italic> MGH78578, triggering oxidative stress and a <italic>triclosan-like</italic> mechanism to exert their anti-<italic>Klebsiella</italic> effect. With toxicity studies in appropriate cell models, L-Ag NPs may be a future candidate as an antimicrobial agent. We hypothesized that our RNA-seq data could provide clues as to how <italic>K. pneumoniae</italic> might develop resistance against L-Ag NPs. Genes including <italic>rbsD/C</italic>, <italic>trkA</italic>, <italic>pcnB</italic>, and <italic>infB</italic> were downregulated during the adaptive response at 30 min. Transposon insertional mutants in <italic>E. coli</italic> genes <italic>trkA</italic>, <italic>pcnB</italic>, and <italic>infB</italic> exhibit better survival in the presence of triclosan (<xref ref-type="bibr" rid="B71">Yasir et al., 2020</xref>). Further, transposon insertion in <italic>rbsB</italic>, inhibiting the periplasmic ribose-binding domain of the RbsABC ribose importer, gave a selective survival advantage in the presence of triclosan. We hypothesize that by downregulating these genes during the adaptive response, <italic>K. pneumoniae</italic> MGH78578 could elicit strategies to combat the effects of exposure whilst resistance against L-Ag NPs. Exposure to sub-inhibitory concentrations of antimicrobial compounds is one of the main drivers in the evolution of AMR. By continuous exposure to sub-inhibitory concentrations of silver and the subsequent downregulation of these genes, <italic>K. pneumoniae</italic> might offer a transient resistance to L-Ag NPs. This hysteresis effect might be the prelude to developing a fully expressed antimicrobial resistance mechanism against silver. However, the triclosan-like antibacterial action mechanism could be a <italic>Klebsiella</italic> specific effect. The reproduction of this effect in other bacterial pathogens needs to be experimentally evaluated.</p>
</sec>
</sec>
<sec id="S4">
<title>Data Availability Statement</title>
<p>The RNAseq data produced from the present work were deposited to the NCBI-GEO database and are available under the accession number <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="GSE151953">GSE151953</ext-link>.</p>
</sec>
<sec id="S5">
<title>Author Contributions</title>
<p>SD, SS, SF, VP, and JP designed the study. VP, AB, and SD characterized the silver NPs. VP and SS carried out the RNA-seq experiments. SKS generated the bioinformatics based gene expression dataset. SS, SD, VP, and SF carried out the detailed RNA-seq dataset analysis that led to the triclosan observation. All authors read and approved the manuscript.</p>
</sec>
<sec sec-type="COI-statement" id="conf1">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> VP acknowledges CSIR-SRF [09/719(0090)/2018-EMR-l] and EMBO Short Term Fellowship (ESTF 7654) for the financial support. This project was supported, in part, by the Ulysses PHC Scheme (CNRS).</p>
</fn>
</fn-group>
<ack>
<p>We are thankful to BITS Pilani, University College Dublin, and Universit&#x00E9; de Paris for providing lab facilities. We acknowledge Justine Renault, Linh-Chi Bui, and the Bioprofiler Facility (BFA) for the HPLC analysis.</p>
</ack>
<sec id="S8" sec-type="supplementary material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2021.638640/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmicb.2021.638640/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.xlsx" id="DS1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="Data_Sheet_2.pdf" id="FS1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adamo</surname> <given-names>R.</given-names></name> <name><surname>Margarit</surname> <given-names>I.</given-names></name></person-group> (<year>2018</year>). <article-title>Fighting antibiotic-resistant <italic>Klebsiella pneumoniae</italic> with &#x201C;sweet&#x201D;. immune targets.</article-title> <source><italic>mBio</italic></source> <volume>9</volume>:<issue>e00874-18</issue>.</citation></ref>
<ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname> <given-names>J. W.</given-names></name></person-group> (<year>2009</year>). <article-title>History of the medical use of silver.</article-title> <source><italic>Surg. Infect. (Larchmt.)</italic></source> <volume>10</volume> <fpage>289</fpage>&#x2013;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1089/sur.2008.9941</pub-id> <pub-id pub-id-type="pmid">19566416</pub-id></citation></ref>
<ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anes</surname> <given-names>J.</given-names></name> <name><surname>Dever</surname> <given-names>K.</given-names></name> <name><surname>Eshwar</surname> <given-names>A.</given-names></name> <name><surname>Nguyen</surname> <given-names>S.</given-names></name> <name><surname>Cao</surname> <given-names>Y.</given-names></name> <name><surname>Sivasankaran</surname> <given-names>S. K.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Analysis of the oxidative stress regulon identifies soxS as a genetic target for resistance reversal in multi-drug resistant <italic>Klebsiella pneumoniae</italic>.</article-title> <source><italic>bioRxiv</italic> [preprint]</source> <pub-id pub-id-type="doi">10.1101/2020.08.21.262022</pub-id></citation></ref>
<ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anes</surname> <given-names>J.</given-names></name> <name><surname>Hurley</surname> <given-names>D.</given-names></name> <name><surname>Martins</surname> <given-names>M.</given-names></name> <name><surname>Fanning</surname> <given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Exploring the genome and phenotype of multi-drug resistant <italic>Klebsiella Pneumoniae</italic> Of clinical origin.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>8</volume>:<issue>1913</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2017.01913</pub-id> <pub-id pub-id-type="pmid">29109700</pub-id></citation></ref>
<ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anes</surname> <given-names>J.</given-names></name> <name><surname>Sivasankaran</surname> <given-names>S. K.</given-names></name> <name><surname>Muthappa</surname> <given-names>D. M.</given-names></name> <name><surname>Fanning</surname> <given-names>S.</given-names></name> <name><surname>Srikumar</surname> <given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Exposure to sub-inhibitory concentrations of the chemosensitizer 1-(1-naphthylmethyl)-piperazine creates membrane destabilization in multi-drug resistant <italic>Klebsiella pneumoniae</italic>.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>10</volume>:<issue>92</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.00092</pub-id> <pub-id pub-id-type="pmid">30814979</pub-id></citation></ref>
<ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antoniadou</surname> <given-names>A.</given-names></name> <name><surname>Kontopidou</surname> <given-names>F.</given-names></name> <name><surname>Poulakou</surname> <given-names>G.</given-names></name> <name><surname>Koratzanis</surname> <given-names>E.</given-names></name> <name><surname>Galani</surname> <given-names>I.</given-names></name> <name><surname>Papadomichelakis</surname> <given-names>E.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Colistin-resistant isolates of <italic>Klebsiella pneumoniae</italic> emerging in intensive care unit patients: first report of a multiclonal cluster.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>59</volume> <fpage>786</fpage>&#x2013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkl562</pub-id> <pub-id pub-id-type="pmid">17307769</pub-id></citation></ref>
<ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aranda</surname> <given-names>A.</given-names></name> <name><surname>Sequedo</surname> <given-names>L.</given-names></name> <name><surname>Tolosa</surname> <given-names>L.</given-names></name> <name><surname>Quintas</surname> <given-names>G.</given-names></name> <name><surname>Burello</surname> <given-names>E.</given-names></name> <name><surname>Castell</surname> <given-names>J. V.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: a quantitative method for oxidative stress assessment of nanoparticle-treated cells.</article-title> <source><italic>Toxicol. Vitr.</italic></source> <volume>27</volume> <fpage>954</fpage>&#x2013;<lpage>963</lpage>. <pub-id pub-id-type="doi">10.1016/j.tiv.2013.01.016</pub-id> <pub-id pub-id-type="pmid">23357416</pub-id></citation></ref>
<ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ashraf</surname> <given-names>S.</given-names></name> <name><surname>Chatha</surname> <given-names>M. A.</given-names></name> <name><surname>Ejaz</surname> <given-names>W.</given-names></name> <name><surname>Janjua</surname> <given-names>H. A.</given-names></name> <name><surname>Hussain</surname> <given-names>I.</given-names></name></person-group> (<year>2014</year>). <article-title>Lysozyme-coated silver nanoparticles for differentiating bacterial strains on the basis of antibacterial activity.</article-title> <source><italic>Nanoscale Res. Lett.</italic></source> <volume>9</volume> <fpage>1</fpage>&#x2013;<lpage>10</lpage>.</citation></ref>
<ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baker</surname> <given-names>M. J.</given-names></name> <name><surname>Trevisan</surname> <given-names>J.</given-names></name> <name><surname>Bassan</surname> <given-names>P.</given-names></name> <name><surname>Bhargava</surname> <given-names>R.</given-names></name> <name><surname>Butler</surname> <given-names>H. J.</given-names></name> <name><surname>Dorling</surname> <given-names>K. M.</given-names></name><etal/></person-group> (<year>2014</year>). <article-title>Using Fourier transform IR spectroscopy to analyze biological materials.</article-title> <source><italic>Nat. Protoc.</italic></source> <volume>9</volume>:<issue>1771</issue>.</citation></ref>
<ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baugh</surname> <given-names>S.</given-names></name> <name><surname>Phillips</surname> <given-names>C. R.</given-names></name> <name><surname>Ekanayaka</surname> <given-names>A. S.</given-names></name> <name><surname>Piddock</surname> <given-names>L. J. V.</given-names></name> <name><surname>Webber</surname> <given-names>M. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Inhibition of multidrug efflux as a strategy to prevent biofilm formation.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>69</volume> <fpage>673</fpage>&#x2013;<lpage>681</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkt420</pub-id> <pub-id pub-id-type="pmid">24176982</pub-id></citation></ref>
<ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhargava</surname> <given-names>A.</given-names></name> <name><surname>Pareek</surname> <given-names>V.</given-names></name> <name><surname>Roy Choudhury</surname> <given-names>S.</given-names></name> <name><surname>Panwar</surname> <given-names>J.</given-names></name> <name><surname>Karmakar</surname> <given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>Superior bactericidal efficacy of fucose-functionalized silver nanoparticles against <italic>Pseudomonas aeruginosa</italic> PAO1 and prevention of its colonization on urinary catheters.</article-title> <source><italic>ACS Appl. Mater. Interfaces</italic></source> <volume>10</volume> <fpage>29325</fpage>&#x2013;<lpage>29337</lpage>. <pub-id pub-id-type="doi">10.1021/acsami.8b09475</pub-id> <pub-id pub-id-type="pmid">30096228</pub-id></citation></ref>
<ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buege</surname> <given-names>J. A.</given-names></name> <name><surname>Aust</surname> <given-names>S. D.</given-names></name></person-group> (<year>1978</year>). &#x201C;<article-title>[30] Microsomal lipid peroxidation</article-title>,&#x201D; in <source><italic>Methods in Enzymology</italic></source>, <volume>Vol. 52</volume> <role>eds</role> <person-group person-group-type="editor"><name><surname>Fleischer</surname> <given-names>S.</given-names></name> <name><surname>Packer</surname> <given-names>L.</given-names></name></person-group> (<publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name>), <fpage>302</fpage>&#x2013;<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1016/s0076-6879(78)52032-6</pub-id></citation></ref>
<ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cassini</surname> <given-names>A.</given-names></name> <name><surname>H&#x00F6;gberg</surname> <given-names>L. D.</given-names></name> <name><surname>Plachouras</surname> <given-names>D.</given-names></name> <name><surname>Quattrocchi</surname> <given-names>A.</given-names></name> <name><surname>Hoxha</surname> <given-names>A.</given-names></name> <name><surname>Simonsen</surname> <given-names>G. S.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis.</article-title> <source><italic>Lancet Infect. Dis.</italic></source> <volume>19</volume> <fpage>56</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/S1473-3099(18)30605-4</pub-id></citation></ref>
<ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chambers</surname> <given-names>B. A.</given-names></name> <name><surname>Afrooz</surname> <given-names>A. R. M. N.</given-names></name> <name><surname>Bae</surname> <given-names>S.</given-names></name> <name><surname>Aich</surname> <given-names>N.</given-names></name> <name><surname>Katz</surname> <given-names>L.</given-names></name> <name><surname>Saleh</surname> <given-names>N. B.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Effects of chloride and ionic strength on physical morphology, dissolution, and bacterial toxicity of silver nanoparticles.</article-title> <source><italic>Environ. Sci. Technol.</italic></source> <volume>48</volume> <fpage>761</fpage>&#x2013;<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1021/es403969x</pub-id> <pub-id pub-id-type="pmid">24328237</pub-id></citation></ref>
<ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname> <given-names>S.</given-names></name> <name><surname>Bandyopadhyay</surname> <given-names>A.</given-names></name> <name><surname>Sarkar</surname> <given-names>K.</given-names></name></person-group> (<year>2011</year>). <article-title>Effect of iron oxide and gold nanoparticles on bacterial growth leading towards biological application.</article-title> <source><italic>J. Nanobiotechnology</italic></source> <volume>9</volume>:<issue>34</issue>. <pub-id pub-id-type="doi">10.1186/1477-3155-9-34</pub-id> <pub-id pub-id-type="pmid">21859494</pub-id></citation></ref>
<ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chernousova</surname> <given-names>S.</given-names></name> <name><surname>Epple</surname> <given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Silver as antibacterial agent: ion, nanoparticle, and metal.</article-title> <source><italic>Angew. Chemie Int. Ed Engl.</italic></source> <volume>52</volume> <fpage>1636</fpage>&#x2013;<lpage>1653</lpage>. <pub-id pub-id-type="doi">10.1002/anie.201205923</pub-id> <pub-id pub-id-type="pmid">23255416</pub-id></citation></ref>
<ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chopra</surname> <given-names>I.</given-names></name></person-group> (<year>2007</year>). <article-title>The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern?</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>59</volume> <fpage>587</fpage>&#x2013;<lpage>590</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkm006</pub-id> <pub-id pub-id-type="pmid">17307768</pub-id></citation></ref>
<ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chowdhury</surname> <given-names>S.</given-names></name> <name><surname>Basu</surname> <given-names>A.</given-names></name> <name><surname>Kundu</surname> <given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Green synthesis of protein capped silver nanoparticles from phytopathogenic fungus <italic>Macrophomina phaseolina</italic> (Tassi) Goid with antimicrobial properties against multidrug-resistant bacteria.</article-title> <source><italic>Nanoscale Res. Lett.</italic></source> <volume>9</volume>:<issue>365</issue>. <pub-id pub-id-type="doi">10.1186/1556-276X-9-365</pub-id> <pub-id pub-id-type="pmid">25114655</pub-id></citation></ref>
<ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crobeddu</surname> <given-names>B.</given-names></name> <name><surname>Aragao-Santiago</surname> <given-names>L.</given-names></name> <name><surname>Bui</surname> <given-names>L. C.</given-names></name> <name><surname>Boland</surname> <given-names>S.</given-names></name> <name><surname>Baeza Squiban</surname> <given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Oxidative potential of particulate matter 2.5 as predictive indicator of cellular stress.</article-title> <source><italic>Environ. Pollut.</italic></source> <volume>230</volume> <fpage>125</fpage>&#x2013;<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1016/j.envpol.2017.06.051</pub-id> <pub-id pub-id-type="pmid">28649040</pub-id></citation></ref>
<ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dash</surname> <given-names>S.</given-names></name> <name><surname>Sarashetti</surname> <given-names>P. M.</given-names></name> <name><surname>Rajashekar</surname> <given-names>B.</given-names></name> <name><surname>Chowdhury</surname> <given-names>R.</given-names></name> <name><surname>Mukherjee</surname> <given-names>S.</given-names></name></person-group> (<year>2018</year>). <article-title>TGF-&#x03B2;2-induced EMT is dampened by inhibition of autophagy and TNF-&#x03B1; treatment.</article-title> <source><italic>Oncotarget</italic></source> <volume>9</volume>:<issue>6433</issue>. <pub-id pub-id-type="doi">10.18632/oncotarget.23942</pub-id> <pub-id pub-id-type="pmid">29464083</pub-id></citation></ref>
<ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dubbs</surname> <given-names>J. M.</given-names></name> <name><surname>Mongkolsuk</surname> <given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Peroxide-sensing transcriptional regulators in bacteria.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>194</volume> <fpage>5495</fpage>&#x2013;<lpage>5503</lpage>. <pub-id pub-id-type="doi">10.1128/jb.00304-12</pub-id> <pub-id pub-id-type="pmid">22797754</pub-id></citation></ref>
<ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dur&#x00E1;n</surname> <given-names>N.</given-names></name> <name><surname>Dur&#x00E1;n</surname> <given-names>M.</given-names></name> <name><surname>de Jesus</surname> <given-names>M. B.</given-names></name> <name><surname>Seabra</surname> <given-names>A. B.</given-names></name> <name><surname>F&#x00E1;varo</surname> <given-names>W. J.</given-names></name> <name><surname>Nakazato</surname> <given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Silver nanoparticles: a new view on mechanistic aspects on antimicrobial activity.</article-title> <source><italic>Nanomedicine</italic></source> <volume>12</volume> <fpage>789</fpage>&#x2013;<lpage>799</lpage>. <pub-id pub-id-type="doi">10.1016/j.nano.2015.11.016</pub-id> <pub-id pub-id-type="pmid">26724539</pub-id></citation></ref>
<ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eby</surname> <given-names>D. M.</given-names></name> <name><surname>Schaeublin</surname> <given-names>N. M.</given-names></name> <name><surname>Farrington</surname> <given-names>K. E.</given-names></name> <name><surname>Hussain</surname> <given-names>S. M.</given-names></name> <name><surname>Johnson</surname> <given-names>G. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Lysozyme catalyzes the formation of antimicrobial silver nanoparticles.</article-title> <source><italic>ACS Nano</italic></source> <volume>3</volume> <fpage>984</fpage>&#x2013;<lpage>994</lpage>. <pub-id pub-id-type="doi">10.1021/nn900079e</pub-id> <pub-id pub-id-type="pmid">19344124</pub-id></citation></ref>
<ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elkrewi</surname> <given-names>E.</given-names></name> <name><surname>Randall</surname> <given-names>C. P.</given-names></name> <name><surname>Ooi</surname> <given-names>N.</given-names></name> <name><surname>Cottell</surname> <given-names>J. L.</given-names></name> <name><surname>O&#x2019;Neill</surname> <given-names>A. J.</given-names></name></person-group> (<year>2017</year>). <article-title>Cryptic silver resistance is prevalent and readily activated in certain Gram-negative pathogens.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>72</volume> <fpage>3043</fpage>&#x2013;<lpage>3046</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkx258</pub-id> <pub-id pub-id-type="pmid">28981647</pub-id></citation></ref>
<ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gupta</surname> <given-names>A.</given-names></name> <name><surname>Mumtaz</surname> <given-names>S.</given-names></name> <name><surname>Li</surname> <given-names>C. H.</given-names></name> <name><surname>Hussain</surname> <given-names>I.</given-names></name> <name><surname>Rotello</surname> <given-names>V. M.</given-names></name></person-group> (<year>2019</year>). <article-title>Combatting antibiotic-resistant bacteria using nanomaterials.</article-title> <source><italic>Chem. Soc. Rev.</italic></source> <volume>48</volume> <fpage>415</fpage>&#x2013;<lpage>427</lpage>. <pub-id pub-id-type="doi">10.1039/c7cs00748e</pub-id> <pub-id pub-id-type="pmid">30462112</pub-id></citation></ref>
<ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gurbanov</surname> <given-names>R. S.</given-names></name> <name><surname>Ozek</surname> <given-names>N.</given-names></name> <name><surname>Tun&#x00E7;er</surname> <given-names>S.</given-names></name> <name><surname>Severcan</surname> <given-names>F.</given-names></name> <name><surname>Gozen</surname> <given-names>A. G.</given-names></name></person-group> (<year>2018</year>). <article-title>Aspects of silver tolerance in bacteria: infrared spectral changes and epigenetic clues.</article-title> <source><italic>J. Biophotonics</italic></source> <volume>11</volume>:<issue>e201700252</issue>. <pub-id pub-id-type="doi">10.1002/jbio.201700252</pub-id> <pub-id pub-id-type="pmid">29243883</pub-id></citation></ref>
<ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname> <given-names>B. J.</given-names></name> <name><surname>Chin</surname> <given-names>M.</given-names></name> <name><surname>Nusbaum</surname> <given-names>C.</given-names></name> <name><surname>Birren</surname> <given-names>B. W.</given-names></name> <name><surname>Livny</surname> <given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>How deep is deep enough for RNA-Seq profiling of bacterial transcriptomes?</article-title> <source><italic>BMC Genomics</italic></source> <volume>13</volume>:<issue>734</issue>. <pub-id pub-id-type="doi">10.1186/1471-2164-13-734</pub-id> <pub-id pub-id-type="pmid">23270466</pub-id></citation></ref>
<ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>J. H.</given-names></name> <name><surname>Goldstein</surname> <given-names>E. J. C.</given-names></name> <name><surname>Wise</surname> <given-names>J.</given-names></name> <name><surname>Bilker</surname> <given-names>W. B.</given-names></name> <name><surname>Tolomeo</surname> <given-names>P.</given-names></name> <name><surname>Lautenbach</surname> <given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>Epidemiology of carbapenem-resistant <italic>Klebsiella pneumoniae</italic> in a network of long-term acute care hospitals.</article-title> <source><italic>Clin. Infect. Dis.</italic></source> <volume>64</volume> <fpage>839</fpage>&#x2013;<lpage>844</lpage>.</citation></ref>
<ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirakata</surname> <given-names>Y.</given-names></name> <name><surname>Kondo</surname> <given-names>A.</given-names></name> <name><surname>Hoshino</surname> <given-names>K.</given-names></name> <name><surname>Yano</surname> <given-names>H.</given-names></name> <name><surname>Arai</surname> <given-names>K.</given-names></name> <name><surname>Hirotani</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Efflux pump inhibitors reduce the invasiveness of <italic>Pseudomonas aeruginosa</italic>.</article-title> <source><italic>Int. J. Antimicrob. Agents</italic></source> <volume>34</volume> <fpage>343</fpage>&#x2013;<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2009.06.007</pub-id> <pub-id pub-id-type="pmid">19615866</pub-id></citation></ref>
<ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>Y.</given-names></name> <name><surname>Anes</surname> <given-names>J.</given-names></name> <name><surname>Devineau</surname> <given-names>S.</given-names></name> <name><surname>Fanning</surname> <given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title><italic>Klebsiella pneumoniae</italic>: prevalence, reservoirs, antimicrobial resistance, pathogenicity, and infection: a hitherto unrecognized zoonotic bacterium.</article-title> <source><italic>Foodborne Pathog. Dis.</italic></source> <volume>17</volume>. <pub-id pub-id-type="doi">10.1089/fpd.2020.2847</pub-id></citation></ref>
<ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huh</surname> <given-names>A. J.</given-names></name> <name><surname>Kwon</surname> <given-names>Y. J.</given-names></name></person-group> (<year>2011</year>). <article-title>&#x201C;Nanoantibiotics&#x201D;: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.</article-title> <source><italic>J. Control. Release</italic></source> <volume>156</volume> <fpage>128</fpage>&#x2013;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.jconrel.2011.07.002</pub-id> <pub-id pub-id-type="pmid">21763369</pub-id></citation></ref>
<ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jagnow</surname> <given-names>J.</given-names></name> <name><surname>Clegg</surname> <given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title><italic>Klebsiella pneumoniae</italic> MrkD-mediated biofilm formation on extracellular matrix-and collagen-coated surfaces.</article-title> <source><italic>Microbiology</italic></source> <volume>149</volume> <fpage>2397</fpage>&#x2013;<lpage>2405</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.26434-0</pub-id> <pub-id pub-id-type="pmid">12949165</pub-id></citation></ref>
<ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname> <given-names>N.</given-names></name> <name><surname>Bhargava</surname> <given-names>A.</given-names></name> <name><surname>Majumdar</surname> <given-names>S.</given-names></name> <name><surname>Tarafdar</surname> <given-names>J. C.</given-names></name> <name><surname>Panwar</surname> <given-names>J.</given-names></name></person-group> (<year>2011</year>). <article-title>Extracellular biosynthesis and characterization of silver nanoparticles using <italic>Aspergillus flavus</italic> NJP08: a mechanism perspective.</article-title> <source><italic>Nanoscale</italic></source> <volume>3</volume> <fpage>635</fpage>&#x2013;<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1039/c0nr00656d</pub-id> <pub-id pub-id-type="pmid">21088776</pub-id></citation></ref>
<ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname> <given-names>V. C.</given-names></name> <name><surname>Patel</surname> <given-names>S. K. S.</given-names></name> <name><surname>Kang</surname> <given-names>Y. C.</given-names></name> <name><surname>Lee</surname> <given-names>J. K.</given-names></name></person-group> (<year>2019</year>). <article-title>Quorum sensing inhibitors as antipathogens: biotechnological applications.</article-title> <source><italic>Biotechnol. Adv.</italic></source> <volume>37</volume> <fpage>68</fpage>&#x2013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.11.006</pub-id> <pub-id pub-id-type="pmid">30471318</pub-id></citation></ref>
<ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>J.</given-names></name> <name><surname>Dietz</surname> <given-names>M. J.</given-names></name> <name><surname>Hughes</surname> <given-names>K.</given-names></name> <name><surname>Xing</surname> <given-names>M.</given-names></name> <name><surname>Li</surname> <given-names>B.</given-names></name></person-group> (<year>2019</year>). <article-title>Silver nanoparticles present high intracellular and extracellular killing against <italic>Staphylococcus aureus</italic>.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>74</volume> <fpage>1578</fpage>&#x2013;<lpage>1585</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkz053</pub-id> <pub-id pub-id-type="pmid">30778552</pub-id></citation></ref>
<ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klemm</surname> <given-names>E. J.</given-names></name> <name><surname>Wong</surname> <given-names>V. K.</given-names></name> <name><surname>Dougan</surname> <given-names>G.</given-names></name></person-group> (<year>2018</year>). <article-title>Emergence of dominant multidrug-resistant bacterial clades: lessons from history and whole-genome sequencing.</article-title> <source><italic>Proc. Natl. Acad. Sci.U.S.A.</italic></source> <volume>115</volume> <fpage>12872</fpage>&#x2013;<lpage>12877</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1717162115</pub-id> <pub-id pub-id-type="pmid">30559200</pub-id></citation></ref>
<ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krapp</surname> <given-names>A. R.</given-names></name> <name><surname>Rodriguez</surname> <given-names>R. E.</given-names></name> <name><surname>Poli</surname> <given-names>H. O.</given-names></name> <name><surname>Paladini</surname> <given-names>D. H.</given-names></name> <name><surname>Palatnik</surname> <given-names>J. F.</given-names></name> <name><surname>Carrillo</surname> <given-names>N.</given-names></name></person-group> (<year>2002</year>). <article-title>The flavoenzyme ferredoxin (flavodoxin)-NADP (H) reductase modulates NADP (H) homeostasis during the soxRS response of <italic>Escherichia coli</italic>.</article-title> <source><italic>J. Bacteriol.</italic></source> <volume>184</volume> <fpage>1474</fpage>&#x2013;<lpage>1480</lpage>. <pub-id pub-id-type="doi">10.1128/jb.184.5.1474-1480.2002</pub-id> <pub-id pub-id-type="pmid">11844783</pub-id></citation></ref>
<ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Le Ouay</surname> <given-names>B.</given-names></name> <name><surname>Stellacci</surname> <given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>Antibacterial activity of silver nanoparticles: a surface science insight.</article-title> <source><italic>Nano Today</italic></source> <volume>10</volume> <fpage>339</fpage>&#x2013;<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1016/j.nantod.2015.04.002</pub-id></citation></ref>
<ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>G. C.</given-names></name> <name><surname>Burgess</surname> <given-names>D. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Treatment of <italic>Klebsiella pneumoniae</italic> carbapenemase (KPC) infections: a review of published case series and case reports.</article-title> <source><italic>Ann. Clin. Microbiol. Antimicrob.</italic></source> <volume>11</volume>:<issue>32</issue>. <pub-id pub-id-type="doi">10.1186/1476-0711-11-32</pub-id> <pub-id pub-id-type="pmid">23234297</pub-id></citation></ref>
<ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>B.</given-names></name> <name><surname>Zhao</surname> <given-names>Y.</given-names></name> <name><surname>Liu</surname> <given-names>C.</given-names></name> <name><surname>Chen</surname> <given-names>Z.</given-names></name> <name><surname>Zhou</surname> <given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Molecular pathogenesis of <italic>Klebsiella pneumoniae</italic>.</article-title> <source><italic>Future Microbiol.</italic></source> <volume>9</volume> <fpage>1071</fpage>&#x2013;<lpage>1081</lpage>.</citation></ref>
<ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>R.</given-names></name> <name><surname>Chen</surname> <given-names>J.</given-names></name> <name><surname>Cesario</surname> <given-names>T. C.</given-names></name> <name><surname>Wang</surname> <given-names>X.</given-names></name> <name><surname>Yuan</surname> <given-names>J. S.</given-names></name> <name><surname>Rentzepis</surname> <given-names>P. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Synergistic reaction of silver nitrate, silver nanoparticles, and methylene blue against bacteria.</article-title> <source><italic>Proc. Natl. Acad. Sci. U.S.A.</italic></source> <volume>113</volume> <fpage>13612</fpage>&#x2013;<lpage>13617</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1611193113</pub-id> <pub-id pub-id-type="pmid">27849602</pub-id></citation></ref>
<ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Livak</surname> <given-names>K. J.</given-names></name> <name><surname>Schmittgen</surname> <given-names>T. D.</given-names></name></person-group> (<year>2001</year>). <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2- &#x0394;&#x0394;CT method.</article-title> <source><italic>Methods</italic></source> <volume>25</volume> <fpage>402</fpage>&#x2013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1006/meth.2001.1262</pub-id> <pub-id pub-id-type="pmid">11846609</pub-id></citation></ref>
<ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Logan</surname> <given-names>L. K.</given-names></name> <name><surname>Weinstein</surname> <given-names>R. A.</given-names></name></person-group> (<year>2017</year>). <article-title>The epidemiology of Carbapenem-resistant <italic>enterobacteriaceae</italic>: the impact and evolution of a global menace.</article-title> <source><italic>J. Infect. Dis.</italic></source> <volume>215</volume> <fpage>S28</fpage>&#x2013;<lpage>S36</lpage>. <pub-id pub-id-type="doi">10.1093/infdis/jiw282</pub-id> <pub-id pub-id-type="pmid">28375512</pub-id></citation></ref>
<ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lok</surname> <given-names>C.-N.</given-names></name> <name><surname>Ho</surname> <given-names>C.-M.</given-names></name> <name><surname>Chen</surname> <given-names>R.</given-names></name> <name><surname>He</surname> <given-names>Q.-Y.</given-names></name> <name><surname>Yu</surname> <given-names>W.-Y.</given-names></name> <name><surname>Sun</surname> <given-names>H.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Silver nanoparticles: partial oxidation and antibacterial activities.</article-title> <source><italic>JBIC J. Biol. Inorg. Chem.</italic></source> <volume>12</volume> <fpage>527</fpage>&#x2013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1007/s00775-007-0208-z</pub-id> <pub-id pub-id-type="pmid">17353996</pub-id></citation></ref>
<ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Massani</surname> <given-names>M. B.</given-names></name> <name><surname>Klumpp</surname> <given-names>J.</given-names></name> <name><surname>Widmer</surname> <given-names>M.</given-names></name> <name><surname>Speck</surname> <given-names>C.</given-names></name> <name><surname>Nisple</surname> <given-names>M.</given-names></name> <name><surname>Lehmann</surname> <given-names>R.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Chromosomal Sil system contributes to silver resistance in E. coli ATCC 8739.</article-title> <source><italic>BioMetals</italic></source> <volume>31</volume> <fpage>1101</fpage>&#x2013;<lpage>1114</lpage>. <pub-id pub-id-type="doi">10.1007/s10534-018-0143-1</pub-id> <pub-id pub-id-type="pmid">30284644</pub-id></citation></ref>
<ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McQuillan</surname> <given-names>J. S.</given-names></name> <name><surname>Groenaga Infante</surname> <given-names>H.</given-names></name> <name><surname>Stokes</surname> <given-names>E.</given-names></name> <name><surname>Shaw</surname> <given-names>A. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Silver nanoparticle enhanced silver ion stress response in <italic>Escherichia coli</italic> K12.</article-title> <source><italic>Nanotoxicology</italic></source> <volume>6</volume> <fpage>857</fpage>&#x2013;<lpage>866</lpage>. <pub-id pub-id-type="doi">10.3109/17435390.2011.626532</pub-id> <pub-id pub-id-type="pmid">22007647</pub-id></citation></ref>
<ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mijnendonckx</surname> <given-names>K.</given-names></name> <name><surname>Leys</surname> <given-names>N.</given-names></name> <name><surname>Mahillon</surname> <given-names>J.</given-names></name> <name><surname>Silver</surname> <given-names>S.</given-names></name> <name><surname>Van Houdt</surname> <given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Antimicrobial silver: uses, toxicity and potential for resistance.</article-title> <source><italic>Biometals</italic></source> <volume>26</volume> <fpage>609</fpage>&#x2013;<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1007/s10534-013-9645-z</pub-id> <pub-id pub-id-type="pmid">23771576</pub-id></citation></ref>
<ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mulani</surname> <given-names>M. S.</given-names></name> <name><surname>Kamble</surname> <given-names>E. E.</given-names></name> <name><surname>Kumkar</surname> <given-names>S. N.</given-names></name> <name><surname>Tawre</surname> <given-names>M. S.</given-names></name> <name><surname>Pardesi</surname> <given-names>K. R.</given-names></name></person-group> (<year>2019</year>). <article-title>Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review.</article-title> <source><italic>Front. Microbiol.</italic></source> <volume>10</volume>:<issue>539</issue>. <pub-id pub-id-type="doi">10.3389/fmicb.2019.00539</pub-id> <pub-id pub-id-type="pmid">30988669</pub-id></citation></ref>
<ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neuner</surname> <given-names>E. A.</given-names></name> <name><surname>Yeh</surname> <given-names>J.-Y.</given-names></name> <name><surname>Hall</surname> <given-names>G. S.</given-names></name> <name><surname>Sekeres</surname> <given-names>J.</given-names></name> <name><surname>Endimiani</surname> <given-names>A.</given-names></name> <name><surname>Bonomo</surname> <given-names>R. A.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Treatment and outcomes in carbapenem-resistant <italic>Klebsiella pneumoniae</italic> bloodstream infections.</article-title> <source><italic>Diagn. Microbiol. Infect. Dis.</italic></source> <volume>69</volume> <fpage>357</fpage>&#x2013;<lpage>362</lpage>.</citation></ref>
<ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname> <given-names>W.</given-names></name> <name><surname>Li</surname> <given-names>D.-W.</given-names></name> <name><surname>Yu</surname> <given-names>P.</given-names></name> <name><surname>Begum</surname> <given-names>A.</given-names></name> <name><surname>Mizushima</surname> <given-names>T.</given-names></name> <name><surname>Kuroda</surname> <given-names>T.</given-names></name><etal/></person-group> (<year>2005</year>). <article-title>Multidrug resistance in <italic>Klebsiella pneumoniae</italic> MGH78578 and cloning of genes responsible for the resistance.</article-title> <source><italic>Biol. Pharm. Bull.</italic></source> <volume>28</volume> <fpage>1505</fpage>&#x2013;<lpage>1508</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.28.1505</pub-id> <pub-id pub-id-type="pmid">16079502</pub-id></citation></ref>
<ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O&#x2019;Rourke</surname> <given-names>A.</given-names></name> <name><surname>Beyhan</surname> <given-names>S.</given-names></name> <name><surname>Choi</surname> <given-names>Y.</given-names></name> <name><surname>Morales</surname> <given-names>P.</given-names></name> <name><surname>Chan</surname> <given-names>A. P.</given-names></name> <name><surname>Espinoza</surname> <given-names>J. L.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Mechanism-of-action classification of antibiotics by global transcriptome profiling.</article-title> <source><italic>Antimicrob. Agents Chemother.</italic></source> <volume>64</volume>:<issue>e01207-19</issue>.</citation></ref>
<ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Otari</surname> <given-names>S. V.</given-names></name> <name><surname>Pawar</surname> <given-names>S. H.</given-names></name> <name><surname>Patel</surname> <given-names>S. K. S.</given-names></name> <name><surname>Singh</surname> <given-names>R. K.</given-names></name> <name><surname>Kim</surname> <given-names>S. Y.</given-names></name> <name><surname>Lee</surname> <given-names>J. H.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Canna edulis leaf extract-mediated preparation of stabilized silver nanoparticles: characterization, antimicrobial activity, and toxicity studies.</article-title> <source><italic>J. Microbiol. Biotechnol.</italic></source> <volume>27</volume> <fpage>731</fpage>&#x2013;<lpage>738</lpage>. <pub-id pub-id-type="doi">10.4014/jmb.1610.10019</pub-id> <pub-id pub-id-type="pmid">28081356</pub-id></citation></ref>
<ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pareek</surname> <given-names>V.</given-names></name> <name><surname>Bhargava</surname> <given-names>A.</given-names></name> <name><surname>Panwar</surname> <given-names>J.</given-names></name></person-group> (<year>2020</year>). <article-title>Biomimetic approach for multifarious synthesis of nanoparticles using metal tolerant fungi: a mechanistic perspective.</article-title> <source><italic>Mater. Sci. Eng. B</italic></source> <volume>262</volume>:<issue>114771</issue>. <pub-id pub-id-type="doi">10.1016/j.mseb.2020.114771</pub-id></citation></ref>
<ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pareek</surname> <given-names>V.</given-names></name> <name><surname>Gupta</surname> <given-names>R.</given-names></name> <name><surname>Panwar</surname> <given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Do physico-chemical properties of silver nanoparticles decide their interaction with biological media and bactericidal action? A review.</article-title> <source><italic>Mater. Sci. Eng. C</italic></source> <volume>90</volume> <fpage>739</fpage>&#x2013;<lpage>749</lpage>. <pub-id pub-id-type="doi">10.1016/j.msec.2018.04.093</pub-id> <pub-id pub-id-type="pmid">29853145</pub-id></citation></ref>
<ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pelletier</surname> <given-names>D. A.</given-names></name> <name><surname>Suresh</surname> <given-names>A. K.</given-names></name> <name><surname>Holton</surname> <given-names>G. A.</given-names></name> <name><surname>McKeown</surname> <given-names>C. K.</given-names></name> <name><surname>Wang</surname> <given-names>W.</given-names></name> <name><surname>Gu</surname> <given-names>B.</given-names></name><etal/></person-group> (<year>2010</year>). <article-title>Effects of engineered cerium oxide nanoparticles on bacterial growth and viability.</article-title> <source><italic>Appl. Environ. Microbiol.</italic></source> <volume>76</volume> <fpage>7981</fpage>&#x2013;<lpage>7989</lpage>. <pub-id pub-id-type="doi">10.1128/aem.00650-10</pub-id> <pub-id pub-id-type="pmid">20952651</pub-id></citation></ref>
<ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pendleton</surname> <given-names>J. N.</given-names></name> <name><surname>Gorman</surname> <given-names>S. P.</given-names></name> <name><surname>Gilmore</surname> <given-names>B. F.</given-names></name></person-group> (<year>2013</year>). <article-title>Clinical relevance of the ESKAPE pathogens.</article-title> <source><italic>Expert Rev. Anti. Infect. Ther.</italic></source> <volume>11</volume> <fpage>297</fpage>&#x2013;<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1586/eri.13.12</pub-id> <pub-id pub-id-type="pmid">23458769</pub-id></citation></ref>
<ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Podschun</surname> <given-names>R.</given-names></name> <name><surname>Ullmann</surname> <given-names>U.</given-names></name></person-group> (<year>1998</year>). <article-title>Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.</article-title> <source><italic>Clin. Microbiol. Rev.</italic></source> <volume>11</volume> <fpage>589</fpage>&#x2013;<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1128/cmr.11.4.589</pub-id></citation></ref>
<ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname> <given-names>M. K.</given-names></name> <name><surname>Deshmukh</surname> <given-names>S. D.</given-names></name> <name><surname>Ingle</surname> <given-names>A. P.</given-names></name> <name><surname>Gade</surname> <given-names>A. K.</given-names></name></person-group> (<year>2012</year>). <article-title>Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria.</article-title> <source><italic>J. Appl. Microbiol.</italic></source> <volume>112</volume> <fpage>841</fpage>&#x2013;<lpage>852</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2672.2012.05253.x</pub-id> <pub-id pub-id-type="pmid">22324439</pub-id></citation></ref>
<ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Randall</surname> <given-names>C. P.</given-names></name> <name><surname>Gupta</surname> <given-names>A.</given-names></name> <name><surname>Jackson</surname> <given-names>N.</given-names></name> <name><surname>Busse</surname> <given-names>D.</given-names></name> <name><surname>O&#x2019;Neill</surname> <given-names>A. J.</given-names></name></person-group> (<year>2014</year>). <article-title>Silver resistance in Gram-negative bacteria: a dissection of endogenous and exogenous mechanisms.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>70</volume> <fpage>1037</fpage>&#x2013;<lpage>1046</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dku523</pub-id> <pub-id pub-id-type="pmid">25567964</pub-id></citation></ref>
<ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Randall</surname> <given-names>C. P.</given-names></name> <name><surname>Oyama</surname> <given-names>L. B.</given-names></name> <name><surname>Bostock</surname> <given-names>J. M.</given-names></name> <name><surname>Chopra</surname> <given-names>I.</given-names></name> <name><surname>O&#x2019;Neill</surname> <given-names>A. J.</given-names></name></person-group> (<year>2012</year>). <article-title>The silver cation (Ag+): antistaphylococcal activity, mode of action and resistance studies.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>68</volume> <fpage>131</fpage>&#x2013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dks372</pub-id> <pub-id pub-id-type="pmid">23011288</pub-id></citation></ref>
<ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ritchie</surname> <given-names>M. E.</given-names></name> <name><surname>Phipson</surname> <given-names>B.</given-names></name> <name><surname>Wu</surname> <given-names>D.</given-names></name> <name><surname>Hu</surname> <given-names>Y.</given-names></name> <name><surname>Law</surname> <given-names>C. W.</given-names></name> <name><surname>Shi</surname> <given-names>W.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>limma powers differential expression analyses for RNA-sequencing and microarray studies.</article-title> <source><italic>Nucleic Acids Res.</italic></source> <volume>43</volume>:<issue>e47</issue>. <pub-id pub-id-type="doi">10.1093/nar/gkv007</pub-id> <pub-id pub-id-type="pmid">25605792</pub-id></citation></ref>
<ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roe</surname> <given-names>D.</given-names></name> <name><surname>Karandikar</surname> <given-names>B.</given-names></name> <name><surname>Bonn-Savage</surname> <given-names>N.</given-names></name> <name><surname>Gibbins</surname> <given-names>B.</given-names></name> <name><surname>baptiste</surname> <given-names>R. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Antimicrobial surface functionalization of plastic catheters by silver nanoparticles.</article-title> <source><italic>J. Antimicrob. Chemother.</italic></source> <volume>61</volume> <fpage>869</fpage>&#x2013;<lpage>876</lpage>. <pub-id pub-id-type="doi">10.1093/jac/dkn034</pub-id> <pub-id pub-id-type="pmid">18305203</pub-id></citation></ref>
<ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname> <given-names>S. W.</given-names></name> <name><surname>Kim</surname> <given-names>D.</given-names></name> <name><surname>Szubin</surname> <given-names>R.</given-names></name> <name><surname>Palsson</surname> <given-names>B. O.</given-names></name></person-group> (<year>2015</year>). <article-title>Genome-wide reconstruction of OxyR and SoxRS transcriptional regulatory networks under oxidative stress in <italic>Escherichia coli</italic> K-12 MG1655.</article-title> <source><italic>Cell Rep.</italic></source> <volume>12</volume> <fpage>1289</fpage>&#x2013;<lpage>1299</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2015.07.043</pub-id> <pub-id pub-id-type="pmid">26279566</pub-id></citation></ref>
<ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname> <given-names>V. K.</given-names></name> <name><surname>Yngard</surname> <given-names>R. A.</given-names></name> <name><surname>Lin</surname> <given-names>Y.</given-names></name></person-group> (<year>2009</year>). <article-title>Silver nanoparticles: green synthesis and their antimicrobial activities.</article-title> <source><italic>Adv. Colloid Interface Sci.</italic></source> <volume>145</volume> <fpage>83</fpage>&#x2013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.cis.2008.09.002</pub-id> <pub-id pub-id-type="pmid">18945421</pub-id></citation></ref>
<ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shimada</surname> <given-names>T.</given-names></name> <name><surname>Kori</surname> <given-names>A.</given-names></name> <name><surname>Ishihama</surname> <given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Involvement of the ribose operon repressor RbsR in regulation of purine nucleotide synthesis in <italic>Escherichia coli</italic>.</article-title> <source><italic>FEMS Microbiol. Lett.</italic></source> <volume>344</volume> <fpage>159</fpage>&#x2013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1111/1574-6968.12172</pub-id> <pub-id pub-id-type="pmid">23651393</pub-id></citation></ref>
<ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname> <given-names>D. K.</given-names></name> <name><surname>Kumar</surname> <given-names>J.</given-names></name> <name><surname>Sharma</surname> <given-names>V. K.</given-names></name> <name><surname>Verma</surname> <given-names>S. K.</given-names></name> <name><surname>Singh</surname> <given-names>A.</given-names></name> <name><surname>Kumari</surname> <given-names>P.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Mycosynthesis of bactericidal silver and polymorphic gold nanoparticles: physicochemical variation effects and mechanism.</article-title> <source><italic>Nanomedicine</italic></source> <volume>13</volume> <fpage>191</fpage>&#x2013;<lpage>207</lpage>. <pub-id pub-id-type="doi">10.2217/nnm-2017-0235</pub-id> <pub-id pub-id-type="pmid">29199886</pub-id></citation></ref>
<ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Starodub</surname> <given-names>M. E.</given-names></name> <name><surname>Trevors</surname> <given-names>J. T.</given-names></name></person-group> (<year>1989</year>). <article-title>Silver resistance in <italic>Escherichia coli</italic> R1.</article-title> <source><italic>J. Med. Microbiol.</italic></source> <volume>29</volume> <fpage>101</fpage>&#x2013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1099/00222615-29-2-101</pub-id> <pub-id pub-id-type="pmid">2659795</pub-id></citation></ref>
<ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vimbela</surname> <given-names>G. V.</given-names></name> <name><surname>Ngo</surname> <given-names>S. M.</given-names></name> <name><surname>Fraze</surname> <given-names>C.</given-names></name> <name><surname>Yang</surname> <given-names>L.</given-names></name> <name><surname>Stout</surname> <given-names>D. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Antibacterial properties and toxicity from metallic nanomaterials.</article-title> <source><italic>Int. J. Nanomedicine</italic></source> <volume>12</volume> <fpage>3941</fpage>&#x2013;<lpage>3965</lpage>. <pub-id pub-id-type="doi">10.2147/IJN.S134526</pub-id> <pub-id pub-id-type="pmid">28579779</pub-id></citation></ref>
<ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>H.</given-names></name> <name><surname>Joseph</surname> <given-names>J. A.</given-names></name></person-group> (<year>1999</year>). <article-title>Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader.</article-title> <source><italic>Free Radic. Biol. Med.</italic></source> <volume>27</volume> <fpage>612</fpage>&#x2013;<lpage>616</lpage>. <pub-id pub-id-type="doi">10.1016/s0891-5849(99)00107-0</pub-id></citation></ref>
<ref id="B70"><citation citation-type="journal"><collab>World Health Organization</collab> (<year>2019</year>). <source><italic>No Time to Wait: Securing the Future From Drug-Resistant Infections.</italic> Report to the Secretary-General of the United Nations</source>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>.</citation></ref>
<ref id="B71"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yasir</surname> <given-names>M.</given-names></name> <name><surname>Turner</surname> <given-names>A. K.</given-names></name> <name><surname>Bastkowski</surname> <given-names>S.</given-names></name> <name><surname>Baker</surname> <given-names>D.</given-names></name> <name><surname>Page</surname> <given-names>A. J.</given-names></name> <name><surname>Telatin</surname> <given-names>A.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>TraDIS-Xpress: a high-resolution whole-genome assay identifies novel mechanisms of triclosan action and resistance.</article-title> <source><italic>Genome Res.</italic></source> <volume>30</volume> <fpage>239</fpage>&#x2013;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1101/gr.254391.119</pub-id> <pub-id pub-id-type="pmid">32051187</pub-id></citation></ref>
<ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>K.</given-names></name> <name><surname>Setyawati</surname> <given-names>M. I.</given-names></name> <name><surname>Leong</surname> <given-names>D. T.</given-names></name> <name><surname>Xie</surname> <given-names>J.</given-names></name></person-group> (<year>2018</year>). <article-title>Antimicrobial silver nanomaterials.</article-title> <source><italic>Coord. Chem. Rev.</italic></source> <volume>357</volume> <fpage>1</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccr.2017.11.019</pub-id></citation></ref>
<ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>M.</given-names></name> <name><surname>&#x00C5;slund</surname> <given-names>F.</given-names></name> <name><surname>Storz</surname> <given-names>G.</given-names></name></person-group> (<year>1998</year>). <article-title>Activation of the OxyR transcription factor by reversible disulfide bond formation.</article-title> <source><italic>Science</italic></source> <volume>279</volume> <fpage>1718</fpage>&#x2013;<lpage>1722</lpage>. <pub-id pub-id-type="doi">10.1126/science.279.5357.1718</pub-id> <pub-id pub-id-type="pmid">9497290</pub-id></citation></ref>
<ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zou</surname> <given-names>L.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Gao</surname> <given-names>Y.</given-names></name> <name><surname>Ren</surname> <given-names>X.</given-names></name> <name><surname>Rottenberg</surname> <given-names>M. E.</given-names></name> <name><surname>Lu</surname> <given-names>J.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Synergistic antibacterial activity of silver with antibiotics correlating with the upregulation of the ROS production.</article-title> <source><italic>Sci. Rep.</italic></source> <volume>8</volume>:<issue>11131</issue>. <pub-id pub-id-type="doi">10.1038/s41598-018-29313-w</pub-id> <pub-id pub-id-type="pmid">30042429</pub-id></citation></ref>
</ref-list>
</back>
</article>
